Sunshine Group performed well during 9M 2014/15 posting a PAT Rs. 840 million

[SrirangaVeteran]

Sunshine Group performed well during 9M 2014/15 posting a PAT Rs. 840 million, an increase of 8% YOY, on the back of 14% growth in revenue.

The Group recorded a consolidated Revenue of Rs. 12.2 billion for the nine months 31st December 2014, a growth of 14% YoY compared to the same period last year. Group EBIT closed at Rs.1.3 billion in comparison to Rs. 1.1 billion recorded the previous period, posting a growth of 13%.

Group revenue was largely driven by the Healthcare, Agri and FMCG sectors which recorded growths of 11%, 17% and 18% respectively, whilst Group operating profits were boosted by Agri sector.

Healthcare reported Revenue growth, posting Rs. 4.5 billion, compared to Rs. 4.0 billion for the last period. PAT was Rs. 174 million compared to Rs. 242 million for the same period last year. Goodwill written off amounting to Rs. 62 million negatively impacted PAT for 9M 2014/15. Normalized Healthcare PAT amounted to Rs. 236 million.

Agri sector has shown strong Revenue & PAT growth during the 9M 2014/15. Revenue has increased 17% YoY to Rs. 5.3 billion, compared to Rs. 4.5 billion during the same period last year. PAT grew 32% to post Rs. 409 million in 9M 2014/15 against Rs. 311 million in the same period last year.

FMCG revenue stood at Rs. 2.1 billion for 9M 2014/15 up 18% YoY, and PAT grew by 13% YoY to stand at Rs. 254 million.

Power sector revenue for 9M 2014/15 was flat at Rs. 88 million compared to Rs. 89 million. The sector has recorded PAT of Rs. 20 million compared to Rs. 5.4 million recorded in 9M 2013/14.

The packaging sector revenue contracted by 12% YoY to stand at Rs. 186 million. The sector made a loss of Rs. 19 million for the 9M 2014/15.

Further, Profits attributable to equity shareholders of Sunshine Holdings PLC Decreased 5% YoY to stand at Rs. 408 million for 9M 2014/15. EPS for 9M 2014/15 stood at Rs. 3.05 per share, compared to Rs. 3.20 per share for the same period last year.
Source: 2014/15 3QTR Report

[Hybrid]

What is the status on their off shore business?
Have they divested or shifted location?

This company is quite stable with an above par growth in most sectors.
Only issue is that there is ~3% of the shares traded by small time investors.
23% was acquired by Mr. Senthiverl lately reducing the liquidity further.

What are the valuation methods used for the biological assets shown in the BS?
Anyone aware?

[chinwiTop contributor]

Be careful. Do not go over 1 billion.
Next time there may be "one time " over 1 billion.

[Hybrid]

Be careful. Do not go over  1 billion.
Next time there may be "one time " over 1 billion.

Thanks Chinwi,

Until RAVI and RANIL come out boldly and put it indelibly we need to be careful.
They have leftist elements working with them and some drag can be expected pulling them down.

That's why the JVP are spearheading all the investigations and complaints with CID and Bribery etc.